<DOC>
	<DOCNO>NCT01848912</DOCNO>
	<brief_summary>The purpose study find way detect infection earlier patient receive bone marrow transplant . This accomplish continuous individualized monitor heart rate , respiratory rate temperature variability patient population . The investigator collect data determine whether subtle difference heart rate , respiratory rate temperature help physician detect infection earlier order begin faster treatment patient 's condition deteriorates . Blood test also perform check certain biomarkers may indicate infection</brief_summary>
	<brief_title>Temperature , Heart Respiratory Rate Investigation Along With Variability Evaluation Serum Biomarkers ( THRRIVES )</brief_title>
	<detailed_description>In prospective observational study , patient receive bone marrow transplant select continuous monitor heart rate , respiratory temperate variability . Data collect per standard practice use Zephyr Biopatch device , highly compact wireless monitor two small gel electrode , much comfortable previous belt/strap-based monitoring device . The patient ask wear Zephyr Biopatch device approximately 23 hour day , begin day he/she begin bone marrow transplant . The patient ask continue wear device period 10 day he/she longer experience fever . The Zephyr Biopatch device record heart rate , respiratory rate temperature calculation heart rate variability ( HRV ) , respiratory rate variability ( RRV ) temperature variability ( TV ) use Continuous Multiorgan Individualized Variability Analysis ( CIMVATM ) software engine . The variability outcomes look presence , rapidity severity change variability prior onset , diagnosis treatment infection . Bloodwork also perform check certain biomarkers may indicate infection .</detailed_description>
	<criteria>An expected prolonged period neutropenia Completing bone marrow ; Allogeneic and/or autologous transplant OR Induction chemotherapy Inability obtain write informed consent patient legally authorize representative Ongoing treatment active infection ( prophylaxis ) Preexisting severe cardiopulmonary disease ( define EF 40 % , FEV 40 % , interstitial lung disease pulmonary fibrosis ) On betablockers calcium channel blocker Preexisting arrhythmia Permanent pacemaker Inability speak neither English French</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>